In conclusion, this study reports three new patients with MAPKAPK5-related NDD, consolidating the gene-disease association, expanding the clinical and molecular spectrum of the disorder and further delineating this new ultra-rare, but recognisable syndrome. The gene discussed is MAPKAPK5; the disease is Neurodevelopmental delay.